Table 3 Combined HR of AECG-based TWA related to fatal cardiac events by endpoint and study method
Group | No. of studies | HR (95% CI) |
|---|---|---|
Composite endpoint: SCD, cardiac mortality, and severe arrhythmic events | 5 | 5.94 (1.80 to 19.63) |
Endpoint: SCD | 2 | 7.49 (2.65 to 21.15) |
  Sulimov et al. | ||
  Yu et al. | ||
Endpoint: Cardiac mortality | 2 | 4.75 (0.42 to 53.55) |
  Sakaki et al. | ||
  Monasterio et al. | ||
Studies using MMA method | 4 | 9.51 (4.99 to 18.11) |
  Sakaki et al. | ||
  Sulimov et al. | ||
  Yu et al. | ||
  Hoshida et al. |  |  |